Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, July 6, 2023
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
[ Thu, Jul 06th 2023
] - WOPRAI
Whitney Ijem Reiterated (TSHA) at Strong Buy and Held Target at $13 on, Jul 6th, 2023
Whitney Ijem of Canaccord Genuity, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $13 on, Jul 6th, 2023.
Whitney has made no other calls on TSHA in the last 4 months.
There are 6 other peers that have a rating on TSHA. Out of the 6 peers that are also analyzing TSHA, 1 agrees with Whitney's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Lapides of "Morgan Stanley" Maintained at Hold with Decreased Target to $1 on, Thursday, March 30th, 2023
These are the ratings of the 5 analyists that currently disagree with Whitney
- Geulah Livshits of "Chardan Capital" Reiterated at Strong Buy and Held Target at $5 on, Friday, June 30th, 2023
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $6 on, Thursday, June 29th, 2023
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $2 on, Monday, May 15th, 2023
- Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $2 on, Thursday, March 30th, 2023
- Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $4 on, Thursday, March 30th, 2023
